Wildemeersch D

No ORCID on file · 7 papers in corpus
2017
International journal of women's health ·doi:10.2147/ijwh.s122579

The concept of using a frameless intrauterine device (IUD) instead of the conventional plastic framed IUD is not new. Frameless copper IUDs have been available since the late 1990s. They rely on an anchoring system to retain in the uterine …

2016
Clinical medicine insights. Reproductive health ·doi:10.4137/cmrh.s40087

ObjectiveThe aim of this study was to update the clinical experience with the Femilis® 60 levonorgestrel-releasing intrauterine system (LNG-IUS), now up to 10 years in parous and nulliparous women, particularly with regard to ease and safet…

letter 2016
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2016.04.010
2014
Journal of medical primatology ·doi:10.1111/jmp.12096

BackgroundLong-acting, hormonal contraception may increase HIV risk. Copper intrauterine devices (IUDs) could serve as non-hormonal alternatives. We pilot a pigtail macaque model for evaluating HIV susceptibility factors during copper IUD u…

2014
International journal of women's health ·doi:10.2147/ijwh.s63167

BackgroundThe purpose of this study was to examine factors that could help reduce primary perforation during insertion of a framed intrauterine device (IUD) and to determine factors that contribute in generating enough uterine muscle force …

review 2002
Reproductive biomedicine online ·doi:10.1016/s1472-6483(10)61919-0

A low-dose levonorgestrel (LNG)-releasing intrauterine system (IUS) (FibroPlant) has been clinically developed since 1997 for endometrial suppression during hormone replacement therapy in peri- and postmenopausal women, for the treatment of…

article 2001
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception ·doi:10.1080/ejc.6.4.192.198

OBJECTIVES: To evaluate the effect on menstrual pain in women with primary and secondary dysmenorrhea of a novel 'frameless' intrauterine drug delivery system (IUS), FibroPlant-levonorgestrel (LNG) (Contrel Research, Belgium), releasing 14 …